Coming today: Trump’s most aggressive drug pricing move yet image

Politico, October 25, 2018
Dan Diamond, quoting Rachel Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

Some policy experts cheered Trump's ideas, although they had questions about how the plan would work — "If companies won't sell to Medicare at the benchmark price, what happens?" mused Rachel Sachs of Washington University in St. Louis — or how impactful it would really be.

Read more here!

health law policy pharmaceuticals rachel sachs regulation